Alex Seelenberger

BIOTECH LEADERSHIP | STRATEGIC FINANCE | INVESTOR RELATIONS

📍 Chile, Chile🔄 Updated September 2026💼 6 investments📅 17 years investing🗓 Last invested Sep 2012
VC🌍 Chile
6
Total investments
2
Early stage
0
Mid stage
0
Late stage
17y
Years active

Portfolio

3 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Member
Sep 2012
EchoPixel is building a new world of patient care with its interactive, 3D medical visualization software. The True 3D system allows medical professionals to interact with patient-specific organs and tissue in an open 3D space emanating from a display, enabling doctors to immediately identify, evaluate, and dissect clinically significant structures. In diagnostic, surgical planning and image guided treatment applications, EchoPixel is a privately held, venture backed company located in Santa Clara, CA.
Board Member
Jan 2012
Levita Magnetics is committed to improving patient outcomes and quality of life through Magnetic Surgery®, the next step in the evolution of minimally invasive surgery. This innovative technology platform minimizes the footprint of surgery by decreasing the number of incisions and trocars needed in surgical procedures for better cosmetic outcomes. We are developing proprietary technology that maximizes the benefit of Minimally Invasive Surgery - for both surgeons and patients. With this new platform, reduced-port surgeries will be performed with less visible scars, less pain, and faster recovery. Now cleared for both laparoscopic cholecystectomy and bariatric procedures.
Board Member
Oct 2011
The company plans to be a leader in the production, formulation and clinical development of muscle relaxation molecules derived from microalgae. Phytotox expects to commercialize its products for several pharmaceuticals indications through licensing, partnerships or direct sales. To this end the company is preparing an IND package for injectable pharmaceutical applications. This includes product manufacturing and controls, preclinical animal studies and the corresponding clinical program (this last will be designed by or in collaboration with a licensee company). In addittion, an active ingredient for cosmetic applications is under way by our european subsidiary.
Experience · 7 entries
All (7)
Investments (6)
Board (6)
2012
Board Member
Sep 2012
EchoPixel is building a new world of patient care with its interactive, 3D medical visualization software. The True 3D system allows medical professionals to interact with patient-specific organs and tissue in an open 3D space emanating from a display, enabling doctors to immediately identify, evaluate, and dissect clinically significant structures. In diagnostic, surgical planning and image guided treatment applications, EchoPixel is a privately held, venture backed company located in Santa Clara, CA.
Trigemina
Board Member
Mar 2012
Board Member
Jan 2012
Levita Magnetics is committed to improving patient outcomes and quality of life through Magnetic Surgery®, the next step in the evolution of minimally invasive surgery. This innovative technology platform minimizes the footprint of surgery by decreasing the number of incisions and trocars needed in surgical procedures for better cosmetic outcomes. We are developing proprietary technology that maximizes the benefit of Minimally Invasive Surgery - for both surgeons and patients. With this new platform, reduced-port surgeries will be performed with less visible scars, less pain, and faster recovery. Now cleared for both laparoscopic cholecystectomy and bariatric procedures.
2011
PLx Pharma
Board Member
Oct 2011
Board Member
Oct 2011
The company plans to be a leader in the production, formulation and clinical development of muscle relaxation molecules derived from microalgae. Phytotox expects to commercialize its products for several pharmaceuticals indications through licensing, partnerships or direct sales. To this end the company is preparing an IND package for injectable pharmaceutical applications. This includes product manufacturing and controls, preclinical animal studies and the corresponding clinical program (this last will be designed by or in collaboration with a licensee company). In addittion, an active ingredient for cosmetic applications is under way by our european subsidiary.
Show all 7 entries ↓
Investment activity
2009–2012 · 6 investments
200912011220123
Recent (last 2 years)Earlier